Rapport Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & Equivalents | $52.6M | $56.8M | $70.2M | — |
| Accounts Receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Total Current Assets | $498.6M | $309.8M | $150.9M | — |
| Property, Plant & Equipment | $3.0M | $3.5M | $1.9M | — |
| Goodwill | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — |
| Total Assets | $512.4M | $314.9M | $155.4M | — |
| Liabilities | ||||
| Accounts Payable | $4.2M | $2.0M | $2.5M | — |
| Total Current Liabilities | $19.0M | $8.8M | $8.8M | — |
| Long-Term Debt | — | — | — | — |
| Total Liabilities | $27.8M | $9.5M | $14.5M | — |
| Stockholders' Equity | ||||
| Retained Earnings | $-235.2M | $-123.7M | $-45.4M | — |
| Total Stockholders' Equity | $484.7M | $305.4M | $-25.6M | $-10.1M |